These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 22983907)

  • 21. Device therapy for remodeling in congestive heart failure.
    Carraway EA; Rayburn BK
    Curr Heart Fail Rep; 2007 Mar; 4(1):53-8. PubMed ID: 17386187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
    Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurohormonal Antagonists Are Preferred to an Implantable Cardioverter-Defibrillator in Preventing Sudden Death in Heart Failure.
    Packer M
    JACC Heart Fail; 2019 Oct; 7(10):902-906. PubMed ID: 31521684
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacologic and Endovascular Reversal of Left Ventricular Remodeling.
    Jaiswal A; Nguyen VQ; Carry BJ; le Jemtel TH
    J Card Fail; 2016 Oct; 22(10):829-39. PubMed ID: 27109620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacologic treatment of heart failure: general principle].
    Sasayama S
    Nihon Rinsho; 2007 May; 65 Suppl 5():7-13. PubMed ID: 17571359
    [No Abstract]   [Full Text] [Related]  

  • 26. Pathogenesis and pathophysiology of heart failure with reduced ejection fraction: translation to human studies.
    Ge Z; Li A; McNamara J; Dos Remedios C; Lal S
    Heart Fail Rev; 2019 Sep; 24(5):743-758. PubMed ID: 31209771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of left ventricular remodelling after acute myocardial infarction: an update.
    Rossini R; Senni M; Musumeci G; Ferrazzi P; Gavazzi A
    Recent Pat Cardiovasc Drug Discov; 2010 Nov; 5(3):196-207. PubMed ID: 20874671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ventricular remodeling and its prevention in the treatment of heart failure.
    Patten RD; Udelson JE; Konstam MA
    Curr Opin Cardiol; 1998 May; 13(3):162-7. PubMed ID: 9649938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hypertension in patients with heart failure].
    Takekoshi N; Asaji T; Tada N
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():478-83. PubMed ID: 15171419
    [No Abstract]   [Full Text] [Related]  

  • 31. New concepts in post-infarction ventricular remodeling.
    Udelson JE; Patten RD; Konstam MA
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S3-12. PubMed ID: 14564229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of beta-receptor blocker addition to high-dose angiotensin-converting enzyme inhibitor-nitrate therapy in heart failure.
    Levine TB; Levine AB; Keteyian SJ; Narins B
    Clin Cardiol; 1998 Dec; 21(12):899-904. PubMed ID: 9853182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular remodeling: pathophysiology and treatment.
    Sharpe N
    Heart Fail Monit; 2003; 4(2):55-61. PubMed ID: 14724719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction: A Systematic Review and Network Meta-Analysis.
    Tseng AS; Kunze KL; Lee JZ; Amin M; Neville MR; Almader-Douglas D; Killu AM; Madhavan M; Cha YM; Asirvatham SJ; Friedman PA; Gersh BJ; Mulpuru SK
    Circ Arrhythm Electrophysiol; 2019 Jun; 12(6):e006951. PubMed ID: 31159582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular dilatation after myocardial infarction: ACE inhibitors, beta-blockers, or both?
    Anthonio RL; van Veldhuisen DJ; van Gilst WH
    J Cardiovasc Pharmacol; 1998; 32 Suppl 1():S1-8. PubMed ID: 9731689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical advances in the treatment of congestive heart failure.
    Armstrong PW; Moe GW
    Circulation; 1993 Dec; 88(6):2941-52. PubMed ID: 7902784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological left ventricular reverse remodeling in elderly patients receiving optimal therapy for chronic heart failure.
    Cioffi G; Tarantini L; De Feo S; Pulignano G; Del Sindaco D; Stefenelli C; Opasich C
    Eur J Heart Fail; 2005 Oct; 7(6):1040-8. PubMed ID: 16227142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of angiotensin converting enzyme inhibitors and beta-blockers on left ventricular remodeling after coronary artery bypass graft surgery.
    Maruyama Y; Masaki N; Sato S; Kirimura M; Toyama K; Yuhara M; Sasaki O; Kamiyama T; Nishioka T; Ito H; Yoshimoto N
    Int Heart J; 2008 Jul; 49(4):385-90. PubMed ID: 18753722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ventricular remodeling in heart failure and the effect of beta-blockade.
    Udelson JE
    Am J Cardiol; 2004 May; 93(9A):43B-8B. PubMed ID: 15144937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adult congenital heart disease associated with heart failure].
    Tomimatsu H; Toyoda T
    Nihon Rinsho; 2007 May; 65 Suppl 5():527-30. PubMed ID: 17569326
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.